Terapet
PhD in Particle Physics (University of Cambridge, UK), MPhys in Physics (University of Oxford, UK,. Before joining Terapet, Ben held a CIO (Chief Information Officer) position at Milkalyser Ltd, a biotech start-up based in Exeter, UK. At Milkalyser, Ben led the lab and field validation of the company's automated hormone analysis system. Milkalyser was acquired by Lely NV in January 2020. Following the acquisition, Ben acted as the technical contact between the Exeter development team and the parent company. In 2018, Ben completed a PhD at the University of Cambridge, focusing on the analysis of data from the ATLAS detector at the Large Hadron Collider (LHC at CERN) in search of exotic physics processes.
This person is not in the org chart
This person is not in any teams
Terapet
Terapet SA, a CERN startup, develops a novel medical device which enables medical doctors for the first time to monitor the delivered proton dose inside the patients during cancer treatment: in-vivo, non-invasive, in 3D and real-time. This solution ensures that every patient receives the right dose, every time.